Publications

Below is a select list of publications from the Clark lab:

Erickson, CM, Chin, NA, Rosario, HL, Peterson, A, Johnson, SC, Clark, LR. Feasibility of virtual Alzheimer’s biomarker disclosure: Findings from an observational cohort. Alzheimer’s & Dementia: Translational Research and Clinical Interventions , in press.

Erickson, CM, Chin, NA, Ketchum, FB, Eveler, M, Conway, CE, Coghlin, DM, Clark, LR. The room where it happens: Clinician reflections on returning preclinical Alzheimer’s biomarker results to research participants. Journal of Prevention of Alzheimer’s Disease, in press.

Ketchum, FB, Chin, NA, Erickson, C, Basche, K, Gleason, CE, Clark, L.R.  The importance of the dyad: Participant perspectives on sharing biomarker results in Alzheimer’s disease research. Alzheimer’s & Dementia: Translational Research and Clinical Interventions, in press.

Clark LR, Erickson CM, Jonaitis EM, Ma Y, Chin NA, Basche K, Ketchum FB, Gleason CE. Anticipated reactions to learning Alzheimer’s disease biomarker results. Alzheimers Res Ther. 2022 Jun 22;14(1):85. doi: 10.1186/s13195-022-01027-2. PubMed PMID: 35733219; PubMed Central PMCID: PMC9214979.

Erickson CM, Clark LR, Ketchum FB, Chin NA, Gleason CE, Largent EA. Implications of preclinical Alzheimer’s disease biomarker disclosure for US policy and society. Alzheimers Dement (Amst). 2022;14(1):e12339. doi: 10.1002/dad2.12339. eCollection 2022. PubMed PMID: 36035626; PubMed Central PMCID: PMC9405485.

Ketchum FB, Chin NA, Grill J, Gleason CE, Erickson C, Clark LR, Paulsen JS, Kind AJH. Moving beyond disclosure: Stages of care in preclinical Alzheimer’s disease biomarker testing. Alzheimers Dement. 2022 Oct;18(10):1969-1979. doi: 10.1002/alz.12620. Epub 2022 Feb 25. PubMed PMID: 35213786; PubMed Central PMCID: PMC9402800.

Erickson CM, Clark LR, Umucu E, Vo NH, Volgman AS, Chin NA, Ketchum FB, Jones CH, Gleason CE, Aggarwal NT. Cardiology clinic patient attitudes toward and potential personal utility of genetic testing: Findings from a unique multiracial clinical sample. J Genet Couns. 2022 Aug;31(4):989-997. doi: 10.1002/jgc4.1573. Epub 2022 Apr 23. PubMed PMID: 35460578; PubMed Central PMCID: PMC9545732.

Erickson CM, Chin NA, Ketchum FB, Jonaitis EM, Zuelsdorff ML, Gleason CE, Clark LR. Predictors of Willingness to Enroll in Hypothetical Alzheimer Disease Biomarker Studies that Disclose Personal Results. Alzheimer Dis Assoc Disord. 2022 Apr-Jun 01;36(2):125-132. doi: 10.1097/WAD.0000000000000490. Epub 2022 Feb 4. PubMed PMID: 35125399; PubMed Central PMCID: PMC9132241.

Ketchum FB, Erickson CM, Chin NA, Gleason CE, Lambrou NH, Benton SF, Clark LR. What Influences the Willingness of Blacks and African Americans to Enroll in Preclinical Alzheimer’s Disease Biomarker Research? A Qualitative Vignette Analysis. J Alzheimers Dis. 2022;87(3):1167-1179. doi: 10.3233/JAD-215521. PubMed PMID: 35466937; PubMed Central PMCID: PMC9198766.